What Do Analysts Think About Baxter International Inc. (BAX)?

Baxter International Inc. (NYSE:BAX) is 1 of the apical cheap stocks nether $20 to bargain now. On December 12, Wells Fargo expert Larry Biegelsen reiterated a Hold standing connected Baxter International Inc. (NYSE:BAX) connected December 12 and acceptable a terms people of $19.00. The standing update came aft Baxter International Inc. (NYSE:BAX) announced connected December 11 information successful collaboration with The University of Texas Medical Branch, exhibiting the affirmative effect of astute infusion pump integration with infirmary physics aesculapian records connected the bedside productivity of clinicians, diligent safety, and programming compliance. The information represented the investigation of implicit 1 cardinal intravenous (IV) infusions utilizing Baxter’s Spectrum IQ ample measurement infusion pumps (LVP).

Management stated that the valuation of pre- and post- astute pump EMR integration information revealed a driblet successful diligent information alerts, on with the clip required to programme an infusion and resoluteness a pump alert. The findings frankincense item the imaginable relation of connected infusion therapy to enactment diligent information and code clinician burnout and compliance.

In different development, Baxter International Inc. (NYSE:BAX) received a standing update from Morgan Stanley expert Patrick Wood connected December 2, who chopped the terms people connected the banal to $15 from $19 portion maintaining an Underweight standing connected the shares. The steadfast told investors that MedTech “looks well-positioned connected respective fronts” going into 2026, and believes the upcoming twelvemonth to person “a coagulated manufacture setup”, supported by large merchandise cycles, trough valuations, and a supportive infirmary spending environment.

Baxter International Inc. (NYSE:BAX) provides a portfolio of indispensable healthcare products, which includes parenteral nutrition therapies, acute and chronic dialysis therapies, inhaled anesthetics, generic injectable pharmaceuticals, sterile intravenous (IV) solutions, infusion systems and devices, surgical hemostat and sealant products, surgical equipment, astute furniture systems, diligent monitoring and diagnostic technologies, and respiratory wellness devices. The company’s operations are divided into the pursuing segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom.

While we admit the imaginable of BAX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.